Delivery Order SPE2DR25D2208-SPE2DR26FB4QE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,451.73 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $9,581.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on October 22, 2025, with completion expected by October 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary location for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,720.64 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 19, 2025, with a completion date of August 20, 2025. This delivery order was issued under a firm fixed price arrangement with no set-aside designation, indicating competitive procurement. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,718.82 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on November 28, 2025, with completion scheduled for December 1, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, PA. This delivery order is...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,275.94 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens (0.5 mL) on November 28, 2025, with completion expected by December 1, 2025. This non-set-aside, firm fixed price delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal contract portfolio. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,769.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $3,603.60 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract...
- SPE2DR25D2208Indefinite Delivery Contract
- SPE2DR25D2208-SPE2DR26FB4QEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,076.70 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on November 25, 2025, with completion expected by November 26, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare needs. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, medical devices, vaccines, and related healthcare commodities to support military healthcare programs worldwide. Trulicity, a diabetes treatment medication, represents the type of specialty pharmaceutical product the company routinely delivers through its federal contracts to support Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/24/25 |